Keyword: generics

News

Teva to Sell UK and Irish Assets to Accord Healthcare

07.10.2016 - Israel’s Teva Pharmaceutical Industries is planning to sell the assets of Actavis Generics in the UK and Ireland to Accord Healthcare, a subsidiary of India’s Intas Pharmaceuticals...

Markets & Companies

Bridging the Innovation Gap

02.09.2016 - During the last two decades the pharmaceutical industry was forced to undertake significant structural changes to address mounting challenges from strict regulatory policies, lower...

News

Teva to Buy Anda from Allergan

09.08.2016 - Israel’s Teva Pharmaceutical Industries has agreed to buy Allergan’s generics distributer Anda for $500 million. Anda distributes generic, branded, specialty and over-the-counter...

News

Teva Wins US Nod for Allergan’s Generics

29.07.2016 - Israel’s Teva Pharmaceutical Industries has been cleared by the US Federal Trade Commission (FTC) to proceed with its purchase of Allergan’s generics business after agreeing to...

Logistics & Supply Chain

Pharma Management Radar survey 2016: Escaping the complexity trap

12.05.2016 - The good old days are gone — at least with regard to simplicity in business life. This is particularly true for life sciences companies affected by trends increasing the complexity...

News

Teva says Actavis Closing on Track

11.05.2016 - Israel-based Teva, the world's largest generic drugmaker, still expects its $40.5 billion acquisition of Allergan's generics business, which trades as Actavis, to close in June...

News

Pfizer and Allergan Bury Merger Plans

07.04.2016 - The targeted $160 billion merger between Pfizer and Allergan has run afoul of new anti-inversion legislation proposed by the US Treasury, as had been predicted by most deal...

Markets & Companies

After Pharma’s Patent Cliff

04.04.2016 - Analysts love looking into the future, particularly when it comes to big pharma’s prospect for growth and earnings. The industry experts of Morningstar see slowing patent losses...